Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Orchard therapeutics plc crawled time : 12:03 save search
Orchard Therapeutics Reports 2020 Financial Results and Reviews Recent Accomplishments
Published: 2021-03-02 (Crawled : 12:03) - globenewswire.com
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 1.22%
H: 3.07%
C: -2.8%
financial results results therapeutics
Orchard Therapeutics Announces Interim Data for OTL-203 Showing Positive Clinical Results in Multiple Disease Manifestations of Mucopolysaccharidosis Type I Hurler Syndrome (MPS-IH)
Published: 2021-02-09 (Crawled : 12:03) - globenewswire.com
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 9.9%
H: 10.89%
C: 4.01%
positive disease results syndros mps-ih
Orchard Therapeutics Outlines Comprehensive Presence at 2021 WORLDSymposium™
Published: 2021-01-28 (Crawled : 12:03) - globenewswire.com
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 1.42%
H: 4.03%
C: 0.0%
therapeutics
Orchard Therapeutics Secures Partnerships to Broaden Access to LibmeldyTM for Eligible Patients in Middle East & Turkey
Published: 2021-01-19 (Crawled : 12:03) - globenewswire.com
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 1.55%
H: 0.83%
C: -3.89%
partnership
Orchard Therapeutics Announces OTL-200 Granted Regenerative Medicine Advanced Therapy (RMAT) Designation by FDA for the Treatment of Metachromatic Leukodystrophy (MLD)
Published: 2021-01-14 (Crawled : 12:03) - globenewswire.com
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: -1.61%
H: 15.66%
C: 14.36%
therapy fda treatment designation rmat
Orchard Therapeutics Announces 2021 Corporate Priorities Supporting the Build-out of its Commercial Business in Hematopoietic Stem Cell (HSC) Gene Therapy and Expansion of its Clinical Applications
Published: 2021-01-11 (Crawled : 12:03) - globenewswire.com
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 1.12%
H: 8.69%
C: -7.31%
gene therapy therapy stem cell expansion commercialization gene therapies application
Orchard Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
Published: 2021-01-05 (Crawled : 12:03) - globenewswire.com
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 0.91%
H: 14.0%
C: 9.93%
j.p. morgan healthcare conference
Orchard Therapeutics Receives EC Approval for Libmeldy™ for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD)
Published: 2020-12-21 (Crawled : 12:03) - globenewswire.com
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 2.43%
H: 3.76%
C: -7.52%
approval treatment libmeldy
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M
|
BHIL | $0.1793 -4.37% 19.24% 340K
|
Agriculture, Forestry, Fishing ...
UMAC | $1.48 -1.33% 14.87% 20K
|
CI | $352.28 -0.11% 13.53% 2
|
Health Services
CIG.C | $2.89 -1.37% 12.8% 2.3K
|
n/a
MTH | $154.69 -2.21% 12.68% 450K
|
Consumer Durables
HCP | News | $31.41 7.75% 11.26% 17M
|
TSLA | News | $162.13 12.06% 10.13% 170M
|
Consumer Durables
BMTX 4 | $1.545 0.98% 10.03% 2.5K
|
Information
TAL | $12.26 0.57% 9.22% 12M
|
Consumer Services
Your saved searches
Save your searches and get alerts when important news are released.